These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11736720)

  • 1. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.
    Chan HL; Tang JL; Tam W; Sung JJ
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1899-905. PubMed ID: 11736720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
    Yang YF; Zhao W; Zhong YD; Yang YJ; Shen L; Zhang N; Huang P
    Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
    World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ; Fang F; Guo ZF; Chen Q
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral therapy of chronic hepatitis B patients resistant to lamivudine].
    Cui SN; Wang MM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):395-7. PubMed ID: 16416004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phyllanthus species for chronic hepatitis B virus infection.
    Xia Y; Luo H; Liu JP; Gluud C
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008960. PubMed ID: 21491412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
    Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G
    Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
    Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].
    Mao HY; Shi TD
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):29-33. PubMed ID: 21272455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors predicting the disappearance of virus B replication markers following treatment with lamivudine].
    Buffet C
    Presse Med; 2003 Jan; 32(2):53-4. PubMed ID: 12653025
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymosin alpha-1 treatment in chronic hepatitis B.
    Wu X; Jia J; You H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S129-32. PubMed ID: 25640173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in therapy of chronic hepatitis B.
    Hoofnagle JH
    J Hepatol; 2003; 39 Suppl 1():S230-5. PubMed ID: 14708709
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3 (rd) Month Virological Response to Entecavir Therapy: A Study of Strict Defined Hepatitis B virus Induced Cirrhosis.
    Xu Y; Wu XN; Shi YW; Wei W; Yang AT; Sun YM; Zhao WS; You H
    Chin Med J (Engl); 2015 Jul; 128(14):1867-72. PubMed ID: 26168824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.
    Saruc M; Ozden N; Turkel N; Ayhan S; Hock LM; Tuzcuoglu I; Yuceyar H
    J Pharm Sci; 2003 Jul; 92(7):1386-95. PubMed ID: 12820143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
    Lim SG; Wai CT; Lee YM; Dan YY; Sutedja DS; Wee A; Suresh S; Wu YJ; Machin D; Lim CC; Fock KM; Koay E; Bowden S; Locarnini S; Ishaque SM
    Antivir Ther; 2006; 11(2):245-53. PubMed ID: 16640105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
    Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
    Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda; PEGASYS).
    Chan HL; Wong VW; Chim AM; Wong GL; Chan HY; Sung JJ
    Antivir Ther; 2008; 13(4):555-62. PubMed ID: 18672534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.